These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 18601799)
1. Cost-effectiveness of a new combined immunosuppressive and anti-infectious regimen in kidney transplantation. Wasserfallen JB; Kast-Brückner M; Manuel O; Venetz JP; Meylan PR; Pascual M Int J Technol Assess Health Care; 2008; 24(3):312-7. PubMed ID: 18601799 [TBL] [Abstract][Full Text] [Related]
2. Clinical and economic outcomes of rabbit antithymocyte globulin induction in adults who received kidney transplants from living unrelated donors and received cyclosporine-based immunosuppression. Miller JT; Collins CD; Stuckey LJ; Luan FL; Englesbe MJ; Magee JC; Park JM Pharmacotherapy; 2009 Oct; 29(10):1166-74. PubMed ID: 19792990 [TBL] [Abstract][Full Text] [Related]
3. A randomized, controlled trial of daclizumab vs anti-thymocyte globulin induction for lung transplantation. Mullen JC; Oreopoulos A; Lien DC; Bentley MJ; Modry DL; Stewart K; Winton TL; Jackson K; Doucette K; Preiksaitis J; Halloran PF J Heart Lung Transplant; 2007 May; 26(5):504-10. PubMed ID: 17449421 [TBL] [Abstract][Full Text] [Related]
4. Effect of cytomegalovirus viremia on subclinical rejection or interstitial fibrosis and tubular atrophy in protocol biopsy at 3 months in renal allograft recipients managed by preemptive therapy or antiviral prophylaxis. Reischig T; Jindra P; Hes O; Bouda M; Kormunda S; Treska V Transplantation; 2009 Feb; 87(3):436-44. PubMed ID: 19202451 [TBL] [Abstract][Full Text] [Related]
5. Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience. Thielke JJ; West-Thielke PM; Herren HL; Bareato U; Ommert T; Vidanovic V; Campbell-Lee SA; Tzvetanov IG; Sankary HN; Kaplan B; Benedetti E; Oberholzer J Transplantation; 2009 Jan; 87(2):268-73. PubMed ID: 19155983 [TBL] [Abstract][Full Text] [Related]
6. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival. Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959 [TBL] [Abstract][Full Text] [Related]
7. Cost of renal transplant in Belgium. Chaib-Eddour D; Chaib-Eddour H; Malaise J; Mourad M; Squifflet JP Transplant Proc; 2005; 37(6):2819-20. PubMed ID: 16182818 [TBL] [Abstract][Full Text] [Related]
8. Clinical application of Cordyceps sinensis on immunosuppressive therapy in renal transplantation. Li Y; Xue WJ; Tian PX; Ding XM; Yan H; Pan XM; Feng XS Transplant Proc; 2009 Jun; 41(5):1565-9. PubMed ID: 19545680 [TBL] [Abstract][Full Text] [Related]
9. Kidney transplantation with corticosteroid-free maintenance immunosuppression: a single center analysis of graft and patient survivals. Filipe R; Mota A; Alves R; Bastos C; Macário F; Figueiredo A; Roseiro A; Parada B; Sá H; Nunes P; Bastos M Transplant Proc; 2009 Apr; 41(3):843-5. PubMed ID: 19376367 [TBL] [Abstract][Full Text] [Related]
10. Regimen-related mucosal injury of the gut increased the incidence of CMV disease after allogeneic bone marrow transplantation. Shigematsu A; Yasumoto A; Yamamoto S; Sugita J; Kondo T; Onozawa M; Kahata K; Endo T; Ota S; Sato N; Takahata M; Okada K; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M Biol Blood Marrow Transplant; 2009 Jun; 15(6):679-85. PubMed ID: 19450752 [TBL] [Abstract][Full Text] [Related]
11. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience. Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007 [TBL] [Abstract][Full Text] [Related]
12. A novel immunosuppressive strategy combined with preemptive antiviral therapy improves the eighteen-month mortality in HCV recipients transplanted with aged livers. Urbani L; Mazzoni A; Colombatto P; Bindi L; Biancofiore G; Tascini C; Menichetti F; Brunetto MR; Scatena F; Filipponi F Transplantation; 2008 Dec; 86(12):1666-71. PubMed ID: 19104402 [TBL] [Abstract][Full Text] [Related]
13. Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts. Lachmann N; Terasaki PI; Budde K; Liefeldt L; Kahl A; Reinke P; Pratschke J; Rudolph B; Schmidt D; Salama A; Schönemann C Transplantation; 2009 May; 87(10):1505-13. PubMed ID: 19461487 [TBL] [Abstract][Full Text] [Related]
15. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis. Bemelman FJ; de Maar EF; Press RR; van Kan HJ; ten Berge IJ; Homan van der Heide JJ; de Fijter HW Transplantation; 2009 Aug; 88(3):421-8. PubMed ID: 19667948 [TBL] [Abstract][Full Text] [Related]
17. Patient outcomes and economics of once-daily tacrolimus in renal transplant patients: results of a modeling analysis. Abecassis MM; Seifeldin R; Riordan ME Transplant Proc; 2008 Jun; 40(5):1443-5. PubMed ID: 18589126 [TBL] [Abstract][Full Text] [Related]
18. Transplantation of ABO-incompatible and living unrelated donor-recipient combinations. Ishikawa N; Yagisawa T; Sakuma Y; Fujiwara T; Nukui A; Yashi M; Miyamoto N Transplant Proc; 2008 Sep; 40(7):2292-3. PubMed ID: 18790215 [TBL] [Abstract][Full Text] [Related]
19. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients. Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237 [TBL] [Abstract][Full Text] [Related]
20. High-dose intravenous immunoglobulin and rituximab treatment for antibody-mediated rejection after kidney transplantation: a cost analysis. Tanriover B; Wright SE; Foster SV; Roush KS; Castillo-Lugo JA; Fa K; Levy FL; Mejia A Transplant Proc; 2008 Dec; 40(10):3393-6. PubMed ID: 19100397 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]